DP1 inhibition mitigates the increase in activated/amoeboid microglia associated with both hemorrhagic stroke and ALS (de Boer et al, 2014; Ahmad et al, 2017). This evidence concerns the gene PTGDR and amyotrophic lateral sclerosis.